ArticleScientific reports2025
Comparison of sepsis-associated acute kidney injury with different degrees and causes reveals patterns in mitochondrial metabolism and immune infiltration changes.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mitochondrial lipid remodeling in sepsis-associated acute kidney injury: a cardiolipin-centered convergence framework.Archives of toxicology · 2026Review
- Impact of Melatonin on Sepsis-Associated Acute Kidney Injury in Rat Model of Lipopolysaccharide Endotoxemia.Current issues in molecular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Sepsis-associated acute kidney injury (SA-AKI) is a common complication in critically ill patients, characterized by high morbidity and mortality rates. It remains primarily treated with supportive and nonspecific therapies because of the absence of effective diagnostic biomarkers and therapeutic targets. This study utilized cecal ligation and puncture (CLP) and intraperitoneal injection of lipopolysaccharide (LPS) to create a murine model of SA-AKI, simulating various degrees of severity and aetiologies. Renal transcriptome sequencing was performed, followed by extensive bioinformatic analyses, including gene expression trend analysis using the Mfuzz package, weighted gene co-expression network analysis (WGCNA), protein-protein interaction (PPI) networks, and Cibersort immune infiltration analysis, to uncover key molecular changes in SA-AKI. Transcriptome analysis revealed that SA-AKI induces mitochondrial dysfunction and metabolic disturbances. As the severity of SA-AKI increases, immune-inflammatory activity becomes more pronounced, along with significant metabolic dysfunction. Variations in immune cell infiltration between different aetiologies of SA-AKI suggest distinct immune response patterns and timing. Six hub mitochondrial differentially expressed genes (MitoDEGs) related to SA-AKI severity were identified and validated, showing significant associations with immune cell infiltration. These findings provide valuable insights into SA-AKI pathogenesis and the exploration of therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.